1. Papayan AV, Savenkova ND (red.). Klinicheskaya nefrologiya detskogo vozrasta. Rukovodstvo dlya vrachei. Levsha, SPb., 2008; 600 [Papaian AV, Savenkova ND (red.). Clinicheskaia nefrologiia detskogo vozrasta. Rukovodstvo dlia vrachej. Levsha, SPb., 2008; 600]
2. Vozianov AF, Maidannik VG, Bidnyi VG, Bagdasarova IV. Osnovy nefrologii detskogo vozrasta. Kniga plyus, K., 2002; 348 [Vozianov AF, Majdannik VG, Bidnyj VG, Bagdasarova IV. Osnovy nefrologii detskogo vozrasta. Kniga plius, K., 2002; 348]
3. Utts IA, Kostina ML. Kontseptsiya khronicheskoi bolezni pochek i tubulointerstitsial'nye nefropatii v pediatricheskoi nefrologii. Pediatriya 2008; 87 (1): 146-149 [Utc IA, Kostina ML. Koncepcija hronicheskoj bolezni pochek i tubulointersticial'nye nefropatii v pediatricheskoj nefrologii. Pediatrija 2008; 87 (1): 146-149]
4. Drannik GN, Driyanskaya VE, Gaisenyuk FZ i dr. Faktory mezhkletochnoi kooperatsii v immunogeneze pielonefrita. Immunologiya, allergologiya, infektologiya 2013; 1: 13-19 [Drannik GN, Drijanskaja VE, Gajsenjuk FZ i dr. Faktory mezhkletochnoj kooperacii v immunogeneze pielonefrita. Immunologija, Allergologija, Infektologija 2013; 1: 13-19]
5. Utts IA, Zakharova NB, Kostina ML. Sovremennye aspekty mezhkletochnykh vzaimodeistvii i ikh rol' v geneze tubulointerstitsial'nykh nefropatii. Saratovsk nauch-med zhurn 2007; 3 (3): 44-49 [Utc IA. Zaharova NB, Kostina ML. Sovremennye aspekty mezhkletochnyh vzaimodejstvij i ih rol’ v geneze tubulointersticial’nyh nefropatij. Saratovskij nauchno-medicinskij zhurnal 2007; 3 (3): 44-49]
6. Morozov DA, Morrison VV, Morozova OL i dr. Patogeneticheskie osnovy i sovremennye vozmozhnosti rannei diagnostiki nefroskleroza u detei s puzyrno-mochetochnikovym reflyuksom. Saratovsk nauch-med zhurn 2011; 7 (1): 151-157 [Morozov DA, Morrison VV, Morozova OL i dr. Patogeneticheskie osnovy i sovremennye vozmozhnosti rannej diagnostiki nefroskleroza u detej s puzyrno-mochetochnikovym refljuksom. Saratovskij nauchno-medicinskij zhurnal 2011; 7 (1): 151-157]
7. Mayanskii AN. Tsitokiny i mediatornye funktsii uroepiteliya v vospalitel'nykh reaktsiyakh mochevyvodyashchei sistemy. Tsitokiny i vospalenie 2003; 4: 3-9 [Majanskij AN. Citokiny i mediatornye funkcii urojepitelija v vospalitel’nyh reakcijah mochevyvodjashhej sistemy. Citokiny i vospalenie 2003; 4: 3-9]
8. Ketlinskii SA, Simbirtsev AS. Tsitokiny. Foliant, SPb., 2008; 552 [Ketlinskij SA, Simbircev AS. Citokiny. Foliant, SPb., 2008; 552]
9. Paunova SS, Petrichuk SV, Kucherenko AG i dr. Mediatory vospaleniya i fibrogeneza u detei s infektsiei mochevoi sistemy. Pediatriya 2008; 3: 34-37 [Paunova SS, Petrichuk SV, Kucherenko AG i dr. Mediatory vospalenija i fibrogeneza u detej s infekciej mochevoj sistemy. Pediatrija 2008; 3: 34-37]
10. Bulatova AV, Makarova TP, Mayanskii AN. Diagnosticheskaya znachimost' tsitokinovogo profilya mochi pri khronicheskom pielonefrite u detei. Kazansk med zhurn 2010; 91 (2): 228-232 [Bulatova AV, Makarova TP, Majanskij AN. Diagnosticheskaja znachimost’ citokinovogo profilja mochi pri hronicheskom pielonefrite u detej. Kazanskij medicinskij zhurnal 2010; 91 (2): 228-232]
11. Merkodanova YuA, Utts IA. Tsitokinovyi profil' mochi pri razlichnykh etiopatogeneticheskikh variantakh khronicheskogo pielonefrita u detei. Saratovsk nauch-med zhurn 2011; 7 (4): 901-904. [Merkodanova JuA, Utc IA. Citokinovyj profil’ mochi pri razlichnyh etiopatogeneticheskih variantah hronicheskogo pielonefrita u detej. Saratovskij nauchno-medicinskij zhurnal 2011; 7 (4): 901-904.]
12. Vafina RA, Sagitova GR. Kriterii diagnostiki retsidiva khronicheskogo pielonefrita u detei v ambulatornykh usloviyakh. Fundamental'nye issledovaniya 2014; 10(3): 478-481 [Vafina RA, Sagitova GR. Kriterii diagnostiki recidiva hronicheskogo pielonefrita u detej v ambulatornyh uslovijah. Fundamental’nye issledovanija 2014; 10 - 3: 478-481]
13. Ponomarenko GN (red.). Fizioterapiya: natsional'noe rukovodstvo. GEOTAR-Media, M., 2009; 864 [Ponomarenko GN (red.). Fizioterapija: nacional’noe rukovodstvo. GEOTAR-Media, M., 2009; 864]
14. Neimark AI, Sul'dina AP. Nemedikamentoznye metody v lechenii khronicheskogo pielonefrita. Opyt primeneniya peloidoterapii. Fizioterapiya, bal'neologiya i reabilitatsiya 2014; 3: 44-48 [Nejmark AI, Sul’dina AP. Nemedikamentoznye metody v lechenii hronicheskogo pielonefrita. Opyt primenenija peloidoterapii. Fizioterapija, Bal’neologija i Reabilitacija 2014; 3: 44-48]
15. Khan MA, Novikova EV. Vosstanovitel'noe lechenie detei s khronicheskim pielonefritom. Pediatriya 2011; 90 (3): 128-131 [Han MA, Novikova EV. Vosstanovitel’noe lechenie detej s hronicheskim pielonefritom. Pediatrija 2011; 90 (3): 128-131]
16. Morozova OL, Morozov DA, Zakharova NB. Prichiny i klyuchevye zven'ya patogeneza lokal'nogo vospaleniya v mochevyvodyashchikh putyakh u detei s obstruktivnymi uropatiyami. Pediatriya. Zhurn im. G.N. Speranskogo 2014; 93 (2): 117-123 [Morozova OL, Morozov DA, Zaharova NB. Prichiny i kljuchevye zven’ja patogeneza lokal’nogo vospalenija v mochevyvodjashhih putjah u detej s obstruktivnymi uropatijami. Pediatrija. Zhurnal im. G.N. Speranskogo 2014; 93 (2): 117-123]
17. Khvorostov IN, Zorkin SN, Sminov IE. Mekhanizmy formirovaniya i osobennosti diagnostiki obstruktivnykh uropatii u detei. Vopr sovrem pediatr 2005; 4 (1): 62- 66 [Hvorostov IN, Zorkin SN, Sminov IE. Mehanizmy formirovanija i osobennosti diagnostiki obstruktivnyh uropatij u detej. Voprosy sovremennoj pediatrii 2005; 4 (1): 62- 66]
18. Glybchenko PV, Morozov DA, Svistunov AA, Morozova OL. Novye vozmozhnosti diagnostiki i prognozirovaniya techeniya khronicheskogo obstruktivnogo pielonefrita u detei. Tsitokiny i vospalenie 2009; 8 (3): 64-67 [Glybchenko PV, Morozov DA, Svistunov AA, Morozova OL. Novye vozmozhnosti diagnostiki i prognozirovanija techenija hronicheskogo obstruktivnogo pielonefrita u detej. Citokiny i vospalenie 2009; 8 (3): 64-67]
19. Gewin L, Zent R. How does TGF-β mediate tubulointerstitial fibrosis? Semin Nephrol 2012 May; 32 (3): 228-235
20. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214 (2): 199-210
21. Honda E, Yoshida K, Munakata H. Transforming growth factor-beta upregulates the expression of integrin and related proteins in MRC-5 human myofibroblasts. Tohoku J Exp Med 2010 Apr; 220 (4): 319-327
22. Tesmer LA, Lundy K, Sarksr S et al. Th17 cells in human disease. Immunological Reviews 2008; 223: 87-113
23. Volpe E, Servant N, Zollinger R et al. A critical function for transforming growth factor beta, interleukin 23 and proinflammatory cytokines in driving and modulating human Th-17 responses. Nature Immunology 2008; 9: 650-657
24. Stumhofer JS, Silver J, Hunter CA. Negative regulation of Th17 responses. Semin Immunol 2007; 13: 394-399
25. Kologrivova IV, Kologrivova EN, Suslova TE. Molekulyarnye aspekty funktsionirovaniya T-khelperov 17-go tipa. Byul sibirsk med 2011; 4: 93-99 [Kologrivova IV, Kologrivova EN, Suslova TE. Molekuljarnye aspekty funkcionirovanija T-helperov 17-go tipa. Bjulleten’ sibirskoj mediciny 2011; 4: 93-99]
26. O,Connor W, Zenewicz LA, Flavell RA. The dual nature of Th17 cells: shifting the focus to fanccion. Nature Immunology 2010; 11 (6): 471-476
27. Liang SC, Long AJ, Bennet F et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 2007; 179: 7791-7799
28. Wright JF, Guo Y, Quazi A et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4- T cells. J Boil Chem 2007; 282: 13447-13455
29. Iyoda M, Shibata T, Kawaguchi M et al. IL-17A and IL-17P stimulate chemokines via MAPK pathways (ERK . and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-α and IL-1β. Am J Physiol Renal Physiol 2010; 298 (3): F779-F787
30. Vyalkova AA, Zorin IV. Rol' transformiruyushchego faktora rosta-β v formirovanii i progressirovanii interstitsial'nogo fibroza u detei s puzyrno-mochetochnikovym reflyuksom. Byul Orenburgsk nauchn tsentra NrO RAN (elektronnyi zhurnal http://www.elmag/uran.ru) 2013; 4: 1-9 [Vjalkova AA, Zorin IV. Rol’ transformirujushhego faktora rosta-β v formirovanii i progressirovanii intersticial’nogo fibroza u detej s puzyrno-mochetochnikovym refljuksom. Bjulleten’ Orenburgskogo nauchnogo centra NrO RAN (jelektronnyj zhurnal http://www. elmag/uran.ru) 2013; 4: 1-9]
31. Paunova SS. Patogeneticheskie osnovy formirovaniya reflyuks-nefropatii u detei: Avtoref. dis. … d-ra med nauk, M., 2004; 44 [Paunova SS. Patogeneticheskie osnovy formirovanija refljuks-nefropatii u detej: Avtoref. dis. … d-ra med nauk, M., 2004; 44]
32. Schwentner C, Oswald J, Lunacek A et al. Extracellular microenvironment and cytokine profile of the ureterovesical junction in children with vesicoureteral reflux. J Urol 2008 Aug; 180 (2): 694-700
33. Sadeghi-Bojd S, Kordi-Tamandani DM, Hashemi M. Effect of pro-inflammatory cytokine (IFN-γ +874, IL-18-137 G/C,-607 C/A) genes in relation to risk of vesico-ureteral reflux. Ren Fail 2014 Feb; 36 (1): 1-4
34. Şekerci CA, Işbilen B, Işman F et al. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia. J Urol 2014 Jan; 191 (1): 199-205
35. Yildiz B, Kural N, Colak O et al. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth. Clin Physiol Funct Imaging 2008; 28 (2): 107-112
36. Chertin B, Farkas A, Puri P. Insulin-like growth factor-1 expression in reflux-nephropathy. Pediatr Surg Int 2004; 20 (1): 283-289
37. Rabkin R, Schaefer F. New concepts: growth hormone, insulin-like growth factor-I and the kidney. Growth Horm IGF Res. 2004; 14 (4): 270-276
38. Tomilina NA, Bagdasaryan AR. Mekhanizmy nefroskleroza i farmakologicheskaya ingibitsiya vnutripochechnoi renin-angiotenzinovoi sistemy kak osnova nefroprotektivnoi strategii pri khronicheskikh zabolevaniyakh nativnykh pochek i pochechnogo transplantata. Nefrologiya i dializ 2004; 6 (3): 121-128 [Tomilina NA, Bagdasarjan AR. Mehanizmy nefroskleroza i farmakologicheskaja ingibicija vnutripochechnoj renin-angiotenzinovoj sistemy kak osnova nefroprotektivnoj strategii pri hronicheskih zabolevanijah nativnyh pochek i pochechnogo transplantata. Nefrologija i dializ 2004; 6 (3): 121-128]
39. Rossolovskii AN, Popkov VM, Ponukalin AN, i dr. Klinicheskoe znachenie ekskretsii insulinopodobnogo faktora rosta-1 s mochoi u patsientov s nefrolitiazom. Kurskii nauch-prakt vestn «Chelovek i ego zdorov'e» 2010; 3: 121-127 [Rossolovskij AN, Popkov VM, Ponukalin AN, i dr. Klinicheskoe znachenie jekskrecii insulinopodobnogo faktora rosta-1 s mochoj u pacientov s nefrolitiazom. Kurskij nauchno-prakticheskij vestnik «Chelovek i ego zdorov’e» 2010; 3: 121-127]
40. Morozov DA, Morrison VV, Morozova OL i dr. Patogeneticheskie osnovy i sovremennye vozmozhnosti rannei diagnostiki nefroskleroza u detei s puzyrno-mochetochnikovym reflyuksom. Saratovsk nauch-med zhurn 2011; 7 (1): 151-157 [Morozov DA, Morrison VV, Morozova OL i dr. Patogeneticheskie osnovy i sovremennye vozmozhnosti rannej diagnostiki nefroskleroza u detej s puzyrno-mochetochnikovym refljuksom. Saratovskij nauchno-medicinskij zhurnal 2011; 7 (1): 151-157]
41. Bartoli F, Gesualdo L, Niglio F et el. Xanthogranulomatous pyelonephritis is associated with higher tissue expression of monocyte chemotactic protein-1. Eur J Pediatr Surg 2007; 17 (5): 365-369
42. Tang J, Liu N, Zhuang S. Role of epidermal growth factor receptor in acute and chronic kidney injury. Kidney Int 2013; 83 (5): 804-810
43. Stangou M, Alexopoulos E, Papagianni A et al. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology 2009; 14 (6): 613-620
44. Stangou M, Papagianni A, Bantis C et al. Detection of multiple cytokines in the urine of patients with focal necrotising glomerulonephritis may predict short and long term outcome of renal function. Cytokine 2012; 57 (1): 120-126
45. Tang J, Liu N, Tolbert E et al. Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am J Pathol 2013; 183 (1): 160-172
46. Drannik GM (red.). Klinicheskaya immunologiya i allergologiya: ucheb. Zdorov'e, Kiev, 2006; 888 [Drannik GM (red.). Klinicheskaja immunologija i allergologija: ucheb. Zdorov’ja, K., 2006; 888]
47. Simbirtsev AS. Tsitokinovaya sistema regulyatsii zashchitnykh reaktsii organizma. Tsitokiny i vospalenie 2002; 1: 8-11 [Simbircev AS. Citokinovaja sistema reguljacii zashhitnyh reakcij organizma. Citokiny i vospalenie 2002; 1: 8-11]
48. Buryak VN, Babich VL. Kharakter obshchei immunologicheskoi rezistentnosti u detei s khronicheskim neobstruktivnym pielonefritom. Sovrem pediatr 2014; 2 (58): 111-115 [Burjak VN, Babich VL. Harakter obshhej immunologicheskoj rezistentnosti u detej s hronicheskim neobstruktivnym pielonefritom. Sovremennaja pediatrija 2014; 2 (58): 111-115]